Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Fluoxetine in Japanese Patients with MDD
NCT01808651Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluoxetine in major depressive disorder (MDD), sponsored by Eli Lilly and Company. Started May 2013; status: completed.
02
Drugs
fluoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01808651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01808651.